Viyash Scientific Allots 8,000 Equity Shares Under ESOP 2020
Viyash Scientific Limited has allotted 8,000 equity shares under its ESOP 2020 at an exercise price of Rs. 86 per share. This allotment increases the company's paid-up equity share capital to Rs. 87,37,50,954.
The allotment of a small number of shares under an ESOP is a standard corporate action and is unlikely to have a material impact on the company's overall market valuation or operations.
The announcement is a routine allotment of shares under an existing employee stock option plan and does not significantly impact the company's financial performance or strategic outlook.
Viyash Scientific Limited (formerly known as Sequent Scientific Limited) announced the allotment of 8,000 equity shares of Rs. 2 each, fully paid, to eligible employees. These shares were issued at an exercise price of Rs. 86 per equity share upon the exercise of options granted under the SeQuent ESOP 2020.
The Nomination and Remuneration Committee of the Company approved this allotment via a resolution passed by circulation on April 28, 2026.
Following this allotment, the company's issued and paid-up equity share capital has increased. It now stands at Rs. 87,37,50,954, comprising 43,68,75,477 equity shares of Rs. 2 each, up from the previous Rs. 87,37,34,954, which consisted of 43,68,67,477 equity shares. The newly allotted equity shares will rank pari passu in all respects with the existing equity shares of the Company.
What to do with a filing like this
Viyash Scientific Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Viyash Scientific Limited. Read the original for the full detail.